NCT04638452 Evaluation of Behavioural Psycho & Physiological Responses in People With ASD During a Blood Test in Routine Care Practice
| NCT ID | NCT04638452 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Charles Perrens, Bordeaux |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2021-02-08 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2021-02-08 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project is a prospective study designed to characterize behaviour and its psycho-physiological correlates of participants with ASD (children and adults) in comparison with subjects without ASD matched in age during blood test in common practice.
Eligibility Criteria
Inclusion Criteria: All participants : * Person over 6 years of age * Person who consent to participate in the study * Membership of the social security scheme * Person who not received analgesic treatment that may interfere with pain perception * Person with medical prescription for blood sample Participants with ASD : * Person with ASD diagnosis * If applicable, legal authority consent to participate in the study Exclusion Criteria: All participants : * Person with unstabilized drug therapy * Person with acute or chronic pain * Person with pathology or receiving a treatment which can have an impact in modification of the pain * Person with oculomotor and/or neuro-motor disorders * Pregnant or breastfeeding woman * Person with deprivation of liberty * Person who no consent to participate in the study or no consent to realised video recording Participants without ASD : * Protected adult * Person with ASD diagnosis
Contact & Investigator
Anouck AMESTOY, MD
STUDY DIRECTOR
Physician
Frequently Asked Questions
Who can join the NCT04638452 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 65 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04638452 currently recruiting?
Yes, NCT04638452 is actively recruiting participants. Contact the research team at aamestoy@ch-perrens.fr for enrollment information.
Where is the NCT04638452 trial being conducted?
This trial is being conducted at Bordeaux, France.
Who is sponsoring the NCT04638452 clinical trial?
NCT04638452 is sponsored by Centre Hospitalier Charles Perrens, Bordeaux. The principal investigator is Anouck AMESTOY, MD at Physician. The trial plans to enroll 150 participants.